Searchable abstracts of presentations at key conferences in endocrinology

ea0022p615 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Lanreotide-ATG effectiveness on tumoral mass shrinkage of two thyrotropin-secreting pituitary macroadenomas

Paniagua Amalia , Bernabeu Ignacio , Marazuela Monica

Context: There is scant evidence of tumoral mass reduction in Thyrotropin-secreting pituitary adenomas (TSPA) treated with long-acting somatostatin analogs. There are no reports that evaluate TSPA shrinkage after deep subcutaneous (sc) Lanreotide-ATG (L-ATG) therapy.Objective: The primary objective was to observe if L-ATG could reduce TSPA tumor mass.Methods: A literature review on the subject was made. The biochemical and radiolog...

ea0056p858 | Pituitary - Clinical | ECE2018

Consensus on the management of acromegaly in Spain

Bernabeu Ignacio , Camara Rosa , Marazuela Monica , Domingo Manel Puig

Objective: To find consensus on issues that may raise clinical doubts in the management of patients with acromegaly in Spain.Methods: Nominal group and Delphi methodology was followed. Four experts on acromegaly were selected, who defined important clinical questions in the management of acromegaly. A set recommendations were proposed to solve these questions. Subsequently, a group of 30 additional endocrinologits from all over Spain was selected accordi...

ea0081p226 | Thyroid | ECE2022

HDAC inhibition as a therapy approach in autoimmune thyroid disease

Sacristan-Gomez Pablo , Serrano-Somavilla Ana , Sampedro-Nunez Miguel , Marazuela Monica , Martinez-Hernandez Rebeca

Introduction: Autoimmune Thyroid Diseases (AITD) are one of the most prevalent autoimmune diseases in industrialized countries (5% of population). The two main phenotypes of AITD, Hashimoto thyroiditis (HT) and Graves’ disease (GD), are both characterized by the presence of circulating thyroid antibodies and infiltration by autoreactive lymphocytes in the thyroid gland and sometimes the orbit. One of the most studied mechanisms underlying AITD is the imbalance between imm...

ea0081ep713 | Pituitary and Neuroendocrinology | ECE2022

Bronchial carcinoma as debut in MEN-1 Syndrome

Justel Enriquez Alicia , Torcal Carolina Knott , Blanco Sara Jime nez , Moreno Victor Navas , Marazuela Monica

Background: Neuroendocrine tumors present in the MEN-1 syndrome are usually located in pancreatic islets and more than 10% appear de novo, affecting any age group. The debut of a carcinoid tumor is rare, with a prevalence of 2% of bronchial carcinoid tumors. Materials and methods: We present the case of a 49-year-old woman referred from the Oncology clinic for the assessment of thyroid incidentalomas found in a follow-up CT scan of multifocal bronchial c...

ea0063p1181 | Thyroid 3 | ECE2019

Ethanol ablation of cystic thyroid nodules: an effective and not aggressive treatment

Hernando Inigo , Cuesta Julian , Mingo Alberto , Jimenez Sara , Marazuela Monica , Sampedro-Nunez Miguel Antonio , Lahera Marcos

Introduction: Simple aspiration is the first-line treatment used for benign cystic thyroid nodules. However, a high recurrence rate has been reported with this procedure. When this happens, percutaneous ethanol injection into the nodules has proven to be an effective technique which can reach a volume reduction of about 85% (Kim et al., Eur Radiol. 2012 Jul;22(7):1573–8).Material and methods: Descriptive analysis of percutaneous 96° et...

ea0049ep1481 | Thyroid (non-cancer) | ECE2017

Lymph node categorization as a prognostic factor in a historical series of medullary thyroid cancer cases within a regional hospital

Moreno Nerea Aguirre , Gonzalez Elena Fernandez , Mena Sandra Campos , Azpiroz Monica Marazuela , Vargas Marcos Lahera

Introduction: Medullary thyroid cancer (MTC) TNM classification categorizes lymph nodes (LN) according to their location, but does not consider number and size of LN.Objective: To analyze the relationship between number and size of LN in MCT persistent disease (PD).Material and methods: Retrospective study of patients with MTC followed up in a regional hospital from 1985 to 2015. The main variables (expressed as qualitative in freq...

ea0037ep273 | Calcium and Vitamin D metabolism | ECE2015

Bone mineral density evolution after parathyroidectomy in patients with primary hyperparathyroidism

Vicuna Alicia , Ramos-Levi Ana , Sampedro-Nunez Miguel , Campos Sandra , Zelada Magaly , Marazuela Monica

Introduction: Primary hyperparathyroidism results in increased bone resorption. The presence of osteoporosis is at present an established surgery criteria.Objective: The aim of this study was to evaluate the changes in bone mineral density (BMD) after surgery in patients with primary hyperparathyroidism.Material and methods: Retrospective study of 58 patients with primary hyperparathyroidism treated by parathyroidectomy from 2004 t...

ea0056p49 | Adrenal cortex (to include Cushing's) | ECE2018

Risk estimator for autonomous cortisol secretion in adrenal incidentalomas. Retrospective study of 100 cases

Castro Marta Araujo , Nunez Miguel Sampedro , Gonzalez Elena Fernandez , Moreno Nerea Aguire , Azpiroz Monica Marazuela

Purpose: A combined model of clinical, biochemical and radiological variables could help to predict autonomous cortisol secretion (ACS) in adrenal incidentalomas (AI).Methods: We analyzed retrospectively 100 patients diagnosed of AI between 2011 and 2015. AI was defined as an adrenal mass>1 cm, accidentally discovered by radiologic examination. ACS was ruled out (ACS-) by serum cortisol post-dexamethasone suppression test (Nugent) <3 μg/dl, ...

ea0056p1192 | Thyroid cancer | ECE2018

Tyrosine kinase inhibitors in iodine-refractory thyroid cancer. Clinical experience

Marijuan Clara , Pla Begona , Aguirre Nerea , Fernandez Elena , Hernando Inigo , Jimenez Sara , Marazuela Monica , Lahera Marcos

Introduction: Tyrosine kinase inhibitors (TKIs) are used for treatment of iodine-refractory differentiated thyroid cancer (DTC) in patients with progressive advanced disease.Sorafenib and lenvatinib are the TKIs currently approved for this indication.Objective: To describe the clinical experience in patients with iodine-refractory DTC treated with TKIs in our Institution.Materials and methods: Restrospective cohort study of patient...

ea0063p8 | Adrenal and Neuroendocrine Tumours 1 | ECE2019

Metabolic and cardiovascular profile of 143 adrenal incidentalomas

Araujo-Castro Marta , Nunez Miguel Sampedro , Ramirez Paola Parra , Lazaro Cristina Robles , Hernandez Martin Cuesta , Marazuela Monica

Objective: To study the differences in the metabolic profile of patients with non-functioning adrenal adenomas (NFA) and autonomous cortisol secretion (ACS).Methods: 143 patients diagnosed of adrenal incidentaloma (AI) between 2010 and 2018 were retrospectively analyzed. AI was defined as an adrenal mass≥1 cm, accidentally discovered by radiologic examination. ACS was confirmed by serum cortisol post-dexamethasone suppression test (Nugent)≥3 ...